更新针对针对癌症干细胞的基于免疫的治疗策略
Amirhossein Izadpanah1, Niloufar Mohammadkhani2, Mina Masoudnia3
1Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
Cancer medicine
|September 12, 2023
概括
癌症干细胞 (CSCs) 驱动瘤复发和转移. 免疫疗法提供了一种有前途的策略,以向这些有弹性的细胞,潜在地改善癌症存活率.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症干细胞生物学
背景情况:
- 癌症干细胞 (CSCs) 是瘤内的一个独特的细胞群.
- CSCs具有自我更新,异质性和耐药性,有助于转移和复发.
- 信号通路 (Notch,EMT,Hh,Wnt) 和表面标记物 (CD44,CD133,EpCAM) 对CSC属性至关重要.
研究的目的:
- 审查目前针对癌症干细胞 (CSCs) 的免疫疗法策略.
- 突出CSCs在瘤复发和转移中的作用.
- 讨论免疫疗法在克服传统癌症治疗的局限性方面的潜力.
主要方法:
- 对针对CSCs的免疫疗法进行临床前和临床研究的审查.
- 专注于各种免疫疗法,包括树突细胞 (DC) 疫苗,CAR-T细胞,NK细胞疗法,单克隆抗体 (mAbs),检查点抑制剂和型病毒 (OV).
- 对CSC相关的信号通路和表面标记物的分析.
主要成果:
- 免疫治疗策略在向CSC方面表现有前途,解决化疗和放射治疗的局限性.
- 准特定于CSC的途径和标记物可能会消除瘤并防止复发.
- 该审查涵盖了血液恶性瘤和固体癌症.
结论:
- 免疫疗法代表了一种针对癌症干细胞的新且有效的治疗方法.
- 将免疫疗法与现有治疗相结合可能会改善癌症的整体存活率.
- 进一步的研究和临床研究对于优化这些策略至关重要.
更多相关视频
相关概念视频
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Tumor Immunotherapy
554
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
554
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


